M

MGI Tech Co Ltd
SSE:688114

Watchlist Manager
MGI Tech Co Ltd
SSE:688114
Watchlist
Price: 51.7 CNY -0.58%
Market Cap: 21.5B CNY
Have any thoughts about
MGI Tech Co Ltd?
Write Note

Gross Margin
MGI Tech Co Ltd

60%
Current
56%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
60%
=
Gross Profit
1.5B
/
Revenue
2.6B

Gross Margin Across Competitors

Country CN
Market Cap 21.3B CNY
Gross Margin
60%
Country US
Market Cap 1.2T USD
Gross Margin
55%
Country US
Market Cap 202.3B USD
Gross Margin
41%
Country US
Market Cap 166.6B USD
Gross Margin
60%
Country KR
Market Cap 66.8T KRW
Gross Margin
49%
Country CH
Market Cap 38.4B CHF
Gross Margin
29%
Country US
Market Cap 38.8B USD
Gross Margin
55%
Country US
Market Cap 36.2B USD
Gross Margin
35%
Country US
Market Cap 27B USD
Gross Margin
59%
Country US
Market Cap 24B USD
Gross Margin
35%
Country CN
Market Cap 164.4B CNY
Gross Margin
40%
No Stocks Found

MGI Tech Co Ltd
Glance View

Market Cap
21.3B CNY
Industry
Life Sciences Tools & Services

MGI Tech Co Ltd, a key player in the genomics industry, emerged from the bustling biotech hub of Shenzhen, China, and swiftly carved a niche for itself with cutting-edge sequencing technology. Founded in 2016 as a subsidiary of BGI Group, MGI has dedicated itself to developing advanced genetic sequencing platforms and related products. The company’s mission is clear: to empower life science research and healthcare by providing innovative tools that make sequencing faster, cheaper, and more accessible. At the core of MGI’s success is their proprietary platform sequencing technology, known as the DNBSEQ™, which has garnered attention for its high throughput and accuracy. This technology is pivotal to their business model, as it significantly reduces the cost of sequencing, giving MGI a competitive edge in the market. MGI's business thrives on a dual revenue stream, primarily from the sale of their state-of-the-art sequencing devices and from providing sequencing services. Their portfolio of sequencing platforms, ranging from benchtop sequencers like the MGISEQ-2000 to large-scale units, caters to a diverse clientele, including research institutions, healthcare providers, and industry giants. The company supports this with a robust after-sales service and supply of consumables required for continuous operation, such as reagents and sequencing kits. By embedding itself deeply into the operational frameworks of its clients, MGI not only boosts its device sales but also ensures a persistent revenue flow from ongoing service and supplies. This business model positions MGI Tech Co Ltd as a formidable force, continually driving advancements in genome technology while expanding its global footprint.

Intrinsic Value
39.36 CNY
Overvaluation 24%
Intrinsic Value
Price
M

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
60%
=
Gross Profit
1.5B
/
Revenue
2.6B
What is the Gross Margin of MGI Tech Co Ltd?

Based on MGI Tech Co Ltd's most recent financial statements, the company has Gross Margin of 60%.